register

Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for its New Zealand operations. Bronwen (Bronnie) Marshall will expand her current role as Business Unit Director, Immunology ANZ, to also take on the position of Country Head, New Zealand.

Marshall, who has been with AbbVie for nearly nine years, will succeed El Hussein (Hussein) Abdellatif.

Abdellatif joined the Australia and New Zealand team in January 2023 as Country Manager, taking over from Kylie Pennington, who had been promoted to an international role. Abdellatif has since been elevated to the position of General Manager for AbbVie Gulf-Levant.

“Bronnie is a talented and engaging leader with a clear passion for building high performance teams and developing people,” said Nathalie McNeil, Vice President and General Manager of AbbVie Australia and New Zealand.

“Bronnie’s promotion, along with Hussein’s, highlight AbbVie’s philosophy of empowering employees to advance their career and achieve their personal goals.”

Marshall brings over 20 years of experience in the pharmaceutical industry, with expertise in sales, marketing, and training functions. Her career spans both local and global roles at Genentech, Roche Pharmaceuticals, and Eli Lilly. She holds a Bachelor of Science in Microbiology & Biochemistry (Hons.) from the University of Melbourne.

Since joining AbbVie in 2015, Marshall has held several key positions, including Gastroenterology Business Unit Manager, Group Business Unit Manager, Rheumatology, and most recently, Business Unit Director, Immunology ANZ.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.